Revolutionising Healthcare with Artificial Intelligence
Unlocking the genome and harnessing AI for precision diagnosis of antimicrobial resistanceAbout Us
Powered by artificial intelligence and machine learning, AarogyaAI®’s products rapidly and accurately diagnose drug resistance, enabling clinicians to make data-driven treatment decisions.Learn More
AarogyaAI®’s products are pathogen and sequencing technology agnostic. With a website, mobile and tablet app it can be accessed from anywhere.Learn More
Built and trained on global and local databases as well as extensive literature research, AarogyaAI®’s algorithms detect antimicrobial resistance and search for novel mutations contributing to drug resistanceLearn More
AarogyaAI® showcased its product at significant international and national conferences, like the Centre-State Science Conclave and the Union World Conference on Lung Health.
AarogyaAI®'s R&D, operations and analytics teams expand.
AarogyaAI® raises $700,000 seed funding from Info Edge (India)-backed Redstart Labs and Avaana Capital as well as existing investors Entrepreneur First (EF) and First In Ventures.
Ilumina for start-ups invests in AarogyaAI®’s mission through technical support, genomic sequencing, mentorship and peer learning. First In Ventures, USA was also an investor.
AarogyaAI® raises pre-seed funding of $55,000 from Entrepreneur First, UK.
As a health tech start-up, AarogyaAI® joins the fight against Anti Microbial Resistance (AMR), a growing global threat.
Sign up here for latest updates from us